scholarly article | Q13442814 |
P2093 | author name string | Kuniaki Saito | |
Ekihiro Seki | |||
Masato Hoshi | |||
Hisataka Moriwaki | |||
Atsushi Suetsugu | |||
Yosuke Osawa | |||
Masahito Nagaki | |||
Hiromitsu Kanamori | |||
Hiroyasu Ito | |||
Mitsuru Seishima | |||
Hirofumi Ohtaki | |||
Yoichi Yasuda | |||
P2860 | cites work | Serotonin promotes tumor growth in human hepatocellular cancer | Q24297176 |
Dietary leucine--an environmental modifier of insulin resistance acting on multiple levels of metabolism | Q27334776 | ||
Fatty liver induced by injection of L-tryptophan | Q28237468 | ||
Autophagy regulates lipid metabolism | Q29547421 | ||
Nonalcoholic fatty liver disease | Q29619354 | ||
Hepatic autophagy is suppressed in the presence of insulin resistance and hyperinsulinemia: inhibition of FoxO1-dependent expression of key autophagy genes by insulin | Q30434199 | ||
Target of rapamycin (TOR): balancing the opposing forces of protein synthesis and degradation | Q33540082 | ||
Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis | Q33734679 | ||
Autophagy in health and disease. 2. Regulation of lipid metabolism and storage by autophagy: pathophysiological implications | Q33840453 | ||
Immunohistochemical localization of tryptophan hydroxylase in the human and rat gastrointestinal tracts | Q33869202 | ||
Proteolytic and lipolytic responses to starvation | Q33997322 | ||
L-Tryptophan: Basic Metabolic Functions, Behavioral Research and Therapeutic Indications. | Q34011523 | ||
The target of rapamycin (TOR) proteins | Q34287448 | ||
Roles for C16-ceramide and sphingosine 1-phosphate in regulating hepatocyte apoptosis in response to tumor necrosis factor-alpha | Q34425224 | ||
Acid sphingomyelinase regulates glucose and lipid metabolism in hepatocytes through AKT activation and AMP-activated protein kinase suppression | Q34682367 | ||
Differential effects of long-term leucine infusion on tissue protein synthesis in neonatal pigs | Q35114398 | ||
Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity [corrected] | Q36604703 | ||
Role of serotonin in the hepato-gastroIntestinal tract: an old molecule for new perspectives. | Q37031956 | ||
Mammalian target of rapamycin (mTOR) pathway signalling in lymphomas | Q37074284 | ||
An emerging role of mTOR in lipid biosynthesis. | Q37641438 | ||
The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome | Q37724585 | ||
L-Tryptophan: Biochemical, nutritional and pharmacological aspects | Q38157695 | ||
Rat liver is not damaged by high dose tryptophan treatment | Q38565402 | ||
Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance. | Q40480010 | ||
Immunocytochemical demonstration of 5-hydroxytryptamine in gastrointestinal endocrine cells | Q41019873 | ||
Role of acid sphingomyelinase of Kupffer cells in cholestatic liver injury in mice | Q43263378 | ||
Tissue-specific effects of chronic dietary leucine and norleucine supplementation on protein synthesis in rats | Q44129339 | ||
Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population based study | Q44451078 | ||
Potential role of leucine metabolism in the leucine-signaling pathway involving mTOR. | Q44482073 | ||
Identification of the aromatic L-amino acid decarboxylase gene expression in various mice tissues and its modulation by immobilization stress in stellate ganglia | Q44944608 | ||
The mTOR signaling pathway mediates control of ribosomal protein mRNA translation in rat liver | Q45020034 | ||
Tryptophan loading induces oxidative stress | Q45204042 | ||
Aggravation of viral hepatitis by platelet-derived serotonin | Q45218233 | ||
Rapamycin protects against high fat diet-induced obesity in C57BL/6J mice | Q46047957 | ||
Roles of AKT and sphingosine kinase in the antiapoptotic effects of bile duct ligation in mouse liver | Q46827700 | ||
Promotion of oxidative stress by L-tryptophan in cerebral cortex of rats | Q46960043 | ||
Ultrastructural changes of the liver following L-tryptophan ingestion in rats | Q49011144 | ||
The GCN2 eIF2alpha kinase regulates fatty-acid homeostasis in the liver during deprivation of an essential amino acid. | Q53579178 | ||
Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis. | Q55044281 | ||
Subtle metabolic and liver gene transcriptional changes underlie diet-induced fatty liver susceptibility in insulin-resistant mice | Q58045882 | ||
Tryptophan and the control of triglyceride and carbohydrate metabolism in the rat | Q71206529 | ||
The Absence of IDO Upregulates Type I IFN Production, Resulting in Suppression of Viral Replication in the Retrovirus-Infected Mouse | Q84698033 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 40 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | sirolimus | Q32089 |
liver disease | Q929737 | ||
metabolic dysfunction–associated steatotic liver disease | Q1546498 | ||
fatty liver disease | Q6058862 | ||
P304 | page(s) | 34800-34808 | |
P577 | publication date | 2011-08-12 | |
P1433 | published in | Journal of Biological Chemistry | Q867727 |
P1476 | title | L-tryptophan-mediated enhancement of susceptibility to nonalcoholic fatty liver disease is dependent on the mammalian target of rapamycin | |
P478 | volume | 286 |
Q48032403 | Associations of depression, anxiety and antidepressants with histological severity of nonalcoholic fatty liver disease |
Q47548477 | Cardioprotective effects of dietary rapamycin on adult female C57BLKS/J-Leprdb mice |
Q42504789 | Dietary Tryptophan Enhanced the Expression of Tight Junction Protein ZO-1 in Intestine. |
Q37385498 | Effective treatment with combination of peripheral 5-hydroxytryptamine synthetic inhibitor and 5-hydroxytryptamine 2 receptor antagonist on glucocorticoid-induced whole-body insulin resistance with hyperglycemia |
Q34988970 | Effects of indoleamine 2,3-dioxygenase deficiency on high-fat diet-induced hepatic inflammation |
Q41200837 | Identification of key metabolic changes during liver fibrosis progression in rats using a urine and serum metabolomics approach |
Q38799136 | Important role of 5-hydroxytryptamine in glucocorticoid-induced insulin resistance in liver and intra-abdominal adipose tissue of rats |
Q37059599 | Induction of TDO2 and IDO2 in Liver by High-Fat Feeding in Mice: Discrepancies with Human Obesity |
Q55387515 | Inhibition of Serotonin Synthesis Induces Negative Hepatic Lipid Balance. |
Q37106900 | L-tryptophan metabolism in pregnant mice fed a high L-tryptophan diet and the effect on maternal, placental, and fetal growth |
Q97516977 | LC-MS-Based Metabolomic Study of Oleanolic Acid-Induced Hepatotoxicity in Mice |
Q90602682 | Liver ASK1 protects from non-alcoholic fatty liver disease and fibrosis |
Q36534056 | Long-term Stress with Hyperglucocorticoidemia-induced Hepatic Steatosis with VLDL Overproduction Is Dependent on both 5-HT2 Receptor and 5-HT Synthesis in Liver |
Q92129602 | Maternally Inherited Differences within Mitochondrial Complex I Control Murine Healthspan |
Q31044588 | Metabolomics Coupled with Multivariate Data and Pathway Analysis on Potential Biomarkers in Cholestasis and Intervention Effect of Paeonia lactiflora Pall |
Q92635722 | Pathogens MenTORing Macrophages and Dendritic Cells: Manipulation of mTOR and Cellular Metabolism to Promote Immune Escape |
Q38652774 | Redox Properties of Tryptophan Metabolism and the Concept of Tryptophan Use in Pregnancy |
Q33645106 | Role of serotonin in fatty acid-induced non-alcoholic fatty liver disease in mice |
Q42091299 | Sake lees extract improves hepatic lipid accumulation in high fat diet-fed mice |
Q58577645 | Serotonin induced hepatic steatosis is associated with modulation of autophagy and notch signaling pathway |
Q59136627 | Serotonin signals through a gut-liver axis to regulate hepatic steatosis |
Q41176544 | Serum serotonin reduced the expression of hepatic transporter Mrp2 and P-gp via regulating nuclear receptor CAR in PI-IBS rats |
Q43099927 | Severe everolimus-induced steatohepatis: a case report |
Q37309756 | Subanesthetic doses of ketamine transiently decrease serotonin transporter activity: a PET study in conscious monkeys |
Q89114871 | The gut microbiota metabolite indole alleviates liver inflammation in mice |
Q38081396 | The mTOR pathway in hepatic malignancies |
Q38886658 | l-Tryptophan Activates Mammalian Target of Rapamycin and Enhances Expression of Tight Junction Proteins in Intestinal Porcine Epithelial Cells |
Search more.